"Uncovering the Potential to Target and Prevent Breast Cancer Relapse"

Preventative hormone therapies for breast cancer can inadvertently cause cancer cells to lie dormant and later "wake up" to cause a relapse, but new research suggests that inhibiting an enzyme known as G9a could prevent cancer cells from becoming dormant and kill the cells that are already hibernating, offering new hope for patients with oestrogen receptor positive breast cancer. The findings reveal potential new targets for innovative treatments to prevent breast cancer from recurring, which could significantly impact breast cancer survival rates.